A very strong day for Oncology Pharma Inc. stock price on WednesdayStockInvest.us, 1 year ago
The Oncology Pharma Inc. stock price gained 5.99% on the last trading day (Wednesday, 30th Jun 2021), rising from $26.89 to $28.50. During the day the stock fluctuated 8.58% from a day low at $26.70 to a day high of $28.99. The price has fallen in 7 of the last 10 days and is down by -16.18% for this period. Volume fell on the last day by -27 thousand shares and in total, 139 thousand shares were bought and sold for approximately $3.97 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.Given the current short-term trend, the stock is expected to fall -8.71% during the next 3 months and, with a 90% probability hold a price between $15.56 and $33.97 at the end of this 3-month period.
The Oncology Pharma Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $30.18. On a fall, the stock will find some support from the long-term average at approximately $26.50. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 27, 2021, and so far it has fallen -28.30%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD).
Oncology Pharma Inc. finds support from accumulated volume at $28.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.29 between high and low, or 8.58%. For the last week, the stock has had a daily average volatility of 13.81%.
Oncology Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.Check full Oncology Pharma forecast and analysis here.